Search Team

Search by Last Name

Mayo/Myriad Life Sciences Tracker

Myriad Banner

The Mayo/Myriad Life Sciences Tracker provides a single source for significant decisions in which the patent eligibility of life science claims is addressed under Mayo or Myriad.  Our index of sampled cases is updated regularly and can be filtered on various parameters.  Although this page does not include every decision related to Mayo or Myriad, we strive to capture the most relevant informative decisions, and post new decisions as they are published.

Mayo and Myriad addressed the patent eligibility of subject matter related to natural products and laws of nature, and the outcomes of these cases have significantly changed the landscape for prosecutors and litigators in the life sciences industry.  Since these decisions, the USPTO has issued updated guidance for applicants seeking patent claims to diagnostic methods, biomarker detection, and other life sciences technologies.

Name Date Court Exception Category Significantly More Status
Vanda Pharmaceuticals Vs. West-Ward Pharmaceuticals International 4/13/2018 Fed. Cir. None Not Decided Valid
Pacific Biosciences vs. Oxford Nanopore 3/22/2018 D. Del. None Not Decided Valid
Exergen Corporation v. Kaz USA, Inc. 3/8/2018 Fed. Cir. Law of Nature Yes Valid
Oxford Immunotec, Ltd. v. Qiagen, Inc. 9/26/2017 D. Mass. Law of Nature, Natural Phenomenon Yes Valid
Athena Diagnostics, Inc. v. Mayo Collaborative Services, et al. 8/4/2017 D. Mass. Law of Nature No Invalid
Natural Alternatives International Inc. v. Allmax Nutrition Inc. 6/26/2017 S.D. Cal. Law of Nature, Natural Phenomenon No Invalid
The Cleveland Clinic Foundation v. True Health Diagnostics, LLC 6/16/2017 Fed. Cir. Law of Nature, Natural Phenomenon No Invalid
Viveve Inc. v. Thermigen LLC 4/20/2017 E.D. Tex. None Yes Valid
Boehringer Ingleheim v. HEC Pharma 12/7/2016 D.N.J. Abstract Idea No Invalid
Vanda Pharmaceuticals, Inc. v. Roxane Laboratories, Inc. 8/25/2016 D. Del. Law of Nature Yes Valid
Idexx Laboratories Inc. v. Charles River Laboratories Inc. 7/7/2016 D. Del. Abstract Idea Yes Valid
Rapid Litigation Management v. CellzDirect 7/5/2016 Fed. Cir. None Yes Valid
Genetic Technologies v. Merial 4/8/2016 Fed. Cir. Law of Nature No Invalid
Bristol-Myers Squibb Co. v. Merck 3/29/2016 D. Del. Natural Phenomenon Not Decided Not Decided
Bristol-Myers Squibb Co. v. Merck 3/17/2016 D. Del. Natural Phenomenon Not Decided Not Decided
Rutgers v. Qiagen 2/29/2016 D.N.J. Natural Phenomenon Yes Valid
Xlear, Inc. v. STS Health, LLC 12/15/2015 D. Utah None Not Decided Valid
Mimedx Group Inc. v. Nutech Medical Inc. 11/24/2015 N.D. Ala. Natural Phenomenon Yes / No Valid
Esoterix Genetic Laboratories v. Qiagen, Inc. 9/25/2015 D. Mass. Law of Nature No Invalid
Endo Pharmaceuticals, Inc. v. Actavis, Inc. 9/23/2015 D. Del. Law of Nature No Invalid
load more

What Are Mayo and Myriad?

In Mayo Collaborative Services v. Prometheus Labs., Inc., 132 S. Ct. 1289 (2012), the Supreme Court articulated a two-part analytical framework for determining whether a claim is patent-eligible under 35 U.S.C. § 101.  Mayo dealt with one of three long-established judicial exceptions to patentability under 35 U.S.C. § 101: laws of nature.  In Association for Molecular Pathology v. Myriad Genetics, 133 S.Ct. 2107 (2013), the Court expanded on Mayo to deal with a different judicial exception: natural phenomena (or “products of nature”).

Read more

Fish Resources

Other Resources